Author:
Mayer Geert,Frohnhofen Helmut,Jokisch Martha,Hermann Dirk M.,Gronewold Janine
Abstract
Due to worldwide demographic change, the number of older persons in the population is increasing. Aging is accompanied by changes of sleep structure, deposition of beta-amyloid (Aß) and tau proteins and vascular changes and can turn into mild cognitive impairment (MCI) as well as dementia. Sleep disorders are discussed both as a risk factor for and as a consequence of MCI/dementia. Cross-sectional and longitudinal population-based as well as case–control studies revealed sleep disorders, especially sleep-disorderded breathing (SDB) and excessive or insufficient sleep durations, as risk factors for all-cause MCI/dementia. Regarding different dementia types, SDB was especially associated with vascular dementia while insomnia/insufficient sleep was related to an increased risk of Alzheimer’s disease (AD). Scarce and still inconsistent evidence suggests that therapy of sleep disorders, especially continuous positive airway pressure (CPAP) in SDB, can improve cognition in patients with sleep disorders with and without comorbid dementia and delay onset of MCI/dementia in patients with sleep disorders without previous cognitive impairment. Regarding potential pathomechanisms via which sleep disorders lead to MCI/dementia, disturbed sleep, chronic sleep deficit and SDB can impair glymphatic clearance of beta-amyloid (Aß) and tau which lead to amyloid deposition and tau aggregation resulting in changes of brain structures responsible for cognition. Orexins are discussed to modulate sleep and Aß pathology. Their diurnal fluctuation is suppressed by sleep fragmentation and the expression suppressed at the point of hippocampal atrophy, contributing to the progression of dementia. Additionally, sleep disorders can lead to an increased vascular risk profile and vascular changes such as inflammation, endothelial dysfunction and atherosclerosis which can foster neurodegenerative pathology. There is ample evidence indicating that changes of sleep structure in aging persons can lead to dementia and also evidence that therapy of sleep disorder can improve cognition. Therefore, sleep disorders should be identified and treated early.
Reference128 articles.
1. Neural substrates of awakening probed with optogenetic control of hypocretin neurons;Adamantidis;Nature,2007
2. The effects of light therapy on sleep, depression, neuropsychiatric Behaviors, and cognition among people living with dementia: a meta-analysis of randomized controlled trials;Aini;Am. J. Geriatr. Psychiatry,2023
3. Frequent amyloid deposition without significant cognitive impairment among the elderly;Aizenstein;Arch. Neurol.,2008
4. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study;Ancoli-Israel;J. Am. Geriatr. Soc.,2008
5. A systematic review of meta-analyzes that evaluate risk factors for dementia to evaluate the quantity, quality, and global representativeness of evidence;Anstey;J. Alzheimers Dis.,2019
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献